Krakowski, Aneta D.
Cost, Katherine Tombeau
Anagnostou, Evdokia
Lai, Meng-Chuan
Crosbie, Jennifer
Schachar, Russell
Georgiades, Stelios
Duku, Eric
Szatmari, Peter
Funding for this research was provided by:
Ontario Brain Institute (NA)
Article History
Received: 10 July 2019
Accepted: 15 April 2020
First Online: 25 April 2020
Ethics approval and consent to participate
: Research ethics board approval was obtained at the following POND institutions: Holland Bloorview Research Ethics Board (#11-280); Queen’s University Health Sciences & Affiliated Teaching Hospitals Research Ethics Board (#6005107); The Hospital for Sick Children Research Ethics Board (#1000000346); Hamilton Integrated Research Ethics Board (#12-050); and Western University’s Health Sciences Ethics Board (#103326).
: Not applicable
: RS is in on the scientific advisory board for highland therapeutics and on the scientific advisory board for ehave (psychological software company). RS also has equity in ehave. EA has received consultation fees from Roche and Takeda, royalties from APPI and Springer, and funding from SynapDx and Sanofi-Aventis. PS has received royalties from Guilford Press. AK, KTC, MCL, JC, ED, and SG have no conflicts of interest to declare.